Our site uses cookies to improve functionality. If you are happy with this select "Accept All". If not, select "Manage Preferences" to learn more about managing your cookie preferences. Follow this link to learn more about our cookie policy and how we use cookies. Or learn more about our privacy policy and how we use and store your data.

Cough, Cold and Allergy (Hay Fever) Remedies in the US

October 2022
Select Country Report
USD 1,195
Request More Information

Delivery:

Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).

This report comes in PDF with additional info in Excel included.

Overview:

Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in USA with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.

Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in USA, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.

The Cough, Cold and Allergy (Hay Fever) Remedies in USA report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volume and value sizes, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent research methodology, conducted in-country

This report answers:

  • What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in USA?
  • Which are the leading brands in Cough, Cold and Allergy (Hay Fever) Remedies in USA?
  • How are products distributed in Cough, Cold and Allergy (Hay Fever) Remedies in USA?
  • How has the regulatory and operating environment for Cough, Cold and Allergy (Hay Fever) Remedies changed in USA?
  • How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Cough, Cold and Allergy (Hay Fever) Remedies
  • How significant are wider health concerns and consumer awareness in determining sales?
  • Where is future growth expected to be most dynamic?
Download Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in the US - Category analysis

KEY DATA FINDINGS

Bayer’s Astepro hits the US market following its successful Rx-to-OTC switch
Growth for cough and cold medications due to sharp rise of respiratory illnesses
Still wary about COVID-19, some consumers are eager to pre-emptively treat symptoms
Potentially longer flu seasons can create opportunity for year-round sales
Antihistamines/allergy remedies set to perform well over the forecast period
Herbal/natural trend set to expand, especially for paediatric products
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027

Consumer Health in the US - Industry Overview

Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2021-2022

DISCLAIMER

DEFINITIONS

Summary 2 Research Sources
The following categories and subcategories are included:

Cough, Cold and Allergy (Hay Fever) Remedies

  • Antihistamines/Allergy Remedies (Systemic)
    • Paediatric Allergy Remedies
    • Paediatric Cough/Cold Remedies
  • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
  • Cough Remedies
    • Nasal Sprays
    • Oral Decongestants
    • Inhalant Decongestants
    • Decongestant Rubs
    • Nasal Decongestant Drops
    • Nasal Decongestant Plasters
  • Medicated Confectionery
  • Pharyngeal Preparations

Cough, Cold and Allergy (Hay Fever) Remedies

This is the aggregation of decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, antihistamines and paediatric cough, cold and allergy remedies.

See All of Our Definitions
Share:

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!

© 2023 Euromonitor is privately owned & trademarked. VAT No. GB: 239-2559-40 Registered in England No. 1040587